4.8 Article

Restoration of Sinusoid Fenestrae Followed by Targeted Nanoassembly Delivery of an Anti-Fibrotic Agent Improves Treatment Efficacy in Liver Fibrosis

Related references

Note: Only part of the references are listed.
Review Cardiac & Cardiovascular Systems

New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis

Micheala A. Aldred et al.

Summary: Pulmonary arterial hypertension (PAH) is a complex disease characterized by alterations in the pulmonary circulation, leading to right heart failure and death. Mutations in the BMPRII gene account for a majority of PAH cases, but rare mutations in other genes have also been identified. Understanding these new PAH-related genes can provide insights into the pathogenesis and potential therapeutic targets for this incurable disorder.

CIRCULATION RESEARCH (2022)

Review Cell Biology

The Power of Plasticity?Metabolic Regulation of Hepatic Stellate Cells

Parth Trivedi et al.

Summary: Hepatic stellate cells play a crucial role in regulating physiological and pathological responses in the liver, particularly in chronic liver injury. They drive hepatic fibrosis and are involved in inflammation and cancer by adapting metabolic pathways to meet increased energy demands.

CELL METABOLISM (2021)

Review Gastroenterology & Hepatology

Role of liver sinusoidal endothelial cells in liver diseases

Jordi Gracia-Sancho et al.

Summary: Liver sinusoidal endothelial cells (LSECs) play crucial roles in hepatic homeostasis, being involved in regulation of vascular tone, inflammation, and thrombosis, as well as control of the hepatic immune response. Dysregulations of LSECs in the context of liver disease and hepatocellular carcinoma make them potential therapeutic targets.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Therapeutic pipeline in nonalcoholic steatohepatitis

Raj Vuppalanchi et al.

Summary: The therapeutic pipeline for NASH is expanding with insights into disease pathophysiology, offering potential solutions to resolve steatohepatitis or reverse fibrosis. However, there may be some clinical challenges in the use of these emerging therapies.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Nanoscience & Nanotechnology

Multifunctional biomolecule nanostructures for cancer therapy

Jing Wang et al.

Summary: This review discusses the application of biomolecule-based nanostructures in smart cancer nanomedicine. These multifunctional nanostructures, including polysaccharides, nucleic acids, peptides, and proteins, can achieve targeted drug delivery and transport drugs to tumor tissues.

NATURE REVIEWS MATERIALS (2021)

Review Pharmacology & Pharmacy

Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis

Virender Kumar et al.

Summary: Type 2 diabetes mellitus associated non-alcoholic fatty liver disease is the fourth leading cause of death, with complications such as nephropathy and cirrhosis. Etiological factors involve hyperglycemia and insulin resistance, with treatment targets including FFA homeostasis and lipid metabolism. Strategies to enhance drug delivery to specific liver cell types have the potential to improve efficacy and reduce off-target effects.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Engineering, Biomedical

Extracellular matrix-penetrating nanodrill micelles for liver fibrosis therapy

Qian-Qian Fan et al.

BIOMATERIALS (2020)

Article Chemistry, Physical

Light-triggered NO-releasing nanoparticles for treating mice with liver fibrosis

Hongxia Liang et al.

NANO RESEARCH (2020)

Review Chemistry, Multidisciplinary

Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis

Xue Bai et al.

NANOMATERIALS (2020)

Article Gastroenterology & Hepatology

Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats

Ksenia Brusilovskaya et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2020)

Article Chemistry, Multidisciplinary

Elimination Pathways of Nanoparticles

Wilson Poon et al.

ACS NANO (2019)

Article Chemistry, Multidisciplinary

An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis

Yanping Li et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Article Biochemistry & Molecular Biology

LECT2, a Ligand for Tie1, Plays a Crucial Role in Liver Fibrogenesis

Meng Xu et al.

Review Chemistry, Physical

Self-assembly of peptide-based nanostructures: Synthesis and biological activity

Lena Guyon et al.

NANO RESEARCH (2018)

Article Nanoscience & Nanotechnology

Development of a peptide-modified siRNA nanocomplex for hepatic stellate cells

Zhen Zhao et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)

Article Oncology

Modulation of hepatic stellate cells and reversibility of hepatic fibrosis

Yu Huang et al.

EXPERIMENTAL CELL RESEARCH (2017)

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Chemistry, Multidisciplinary

Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation

Tianjiao Ji et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)

Review Physiology

Promising Therapy Candidates for Liver Fibrosis

Ping Wang et al.

FRONTIERS IN PHYSIOLOGY (2016)

Review Gastroenterology & Hepatology

Antifibrotics in chronic liver disease: tractable targets and translational challenges

Prakash Ramachandran et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Liver Sinusoidal Endothelial Cells in Hepatic Fibrosis

Laurie D. DeLeve

HEPATOLOGY (2015)

Article Medicine, Research & Experimental

Discovery of Peptide Ligands for Hepatic Stellate Cells Using Phage Display

Zhijin Chen et al.

MOLECULAR PHARMACEUTICS (2015)

Review Chemistry, Multidisciplinary

Nanoparticle uptake: The phagocyte problem

Heather Herd Gustafson et al.

NANO TODAY (2015)

Article Multidisciplinary Sciences

BRD4 is a novel therapeutic target for liver fibrosis

Ning Ding et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Materials Science, Biomaterials

Diagnostic imaging and therapeutic application of nanoparticles targeting the liver

Haolu Wang et al.

JOURNAL OF MATERIALS CHEMISTRY B (2015)

Article Physiology

Liver Sinusoidal Endothelial Cells

Karen Kristine Sorensen et al.

COMPREHENSIVE PHYSIOLOGY (2015)

Review Immunology

Liver fibrosis and repair: immune regulation of wound healing in a solid organ

Antonella Pellicoro et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Article Gastroenterology & Hepatology

Inhibition of inflammatory CD4 T cell activity by murine liver sinusoidal endothelial cells

Antonella Carambia et al.

JOURNAL OF HEPATOLOGY (2013)

Article Medicine, General & Internal

Riociguat for the Treatment of Pulmonary Arterial Hypertension

Hossein-Ardeschir Ghofrani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Biochemistry & Molecular Biology

Small-Molecule Inhibition of BRDT for Male Contraception

Martin M. Matzuk et al.

Review Pathology

The liver sieve and atherosclerosis

Robin Fraser et al.

PATHOLOGY (2012)

Review Chemistry, Multidisciplinary

Polymer- and lipid-based nanoparticle therapeutics for the treatment of liver diseases

Lanjuan Li et al.

NANO TODAY (2010)

Article Biotechnology & Applied Microbiology

Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone

Yasushi Sato et al.

NATURE BIOTECHNOLOGY (2008)

Article Cardiac & Cardiovascular Systems

Hyperlipidemia and surfactants: The liver sieve is a link

Victoria C. Cogger et al.

ATHEROSCLEROSIS (2006)

Review Pharmacology & Pharmacy

The hepatic sinusoid in aging and cirrhosis - Effects on hepatic substrate disposition and drug clearance

DG Le Couteur et al.

CLINICAL PHARMACOKINETICS (2005)